1-isopropyl-3-[5-[1-(3-methoxypropyl)-piperidin-4-yl]-[1,2,4]-oxadiazol-3-yl)-1H-indazole

ID: ALA5285364

Chembl Id: CHEMBL5285364

Max Phase: Preclinical

Molecular Formula: C21H29N5O2

Molecular Weight: 383.50

Names and Identifiers

Canonical SMILES:  COCCCN1CCC(c2noc(-c3nn(C(C)C)c4ccccc34)n2)CC1

Standard InChI:  InChI=1S/C21H29N5O2/c1-15(2)26-18-8-5-4-7-17(18)19(23-26)21-22-20(24-28-21)16-9-12-25(13-10-16)11-6-14-27-3/h4-5,7-8,15-16H,6,9-14H2,1-3H3

Standard InChI Key:  KASLEYDBPDYZEO-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5285364

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 383.50

Molecular Weight (Monoisotopic): 383.2321

AlogP: 3.88

#Rotatable Bonds: 7

Polar Surface Area: 69.21

Molecular Species: BASE

HBA: 7

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: 8.89

CX LogP: 3.32

CX LogD: 1.82

Aromatic Rings: 3

Heavy Atoms: 28

QED Weighted: 0.58

Np Likeness Score: -1.66

References

1. Nirogi R, Mohammed AR, Shinde AK, Gagginapally SR, Kancharla DM, Ravella SR, Bogaraju N, Middekadi VR, Subramanian R, Palacharla RC, Benade V, Muddana N, Abraham R, Medapati RB, Thentu JB, Mekala VR, Petlu S, Lingavarapu BB, Yarra S, Kagita N, Goyal VK, Pandey SK, Jasti V..  (2021)  Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT₄ Receptor Partial Agonist for the Treatment of Cognitive Deficits Associated with Alzheimer's Disease.,  64  (15.0): [PMID:34251799] [10.1021/acs.jmedchem.1c00703]

Source

Source(1):

• Scientific Literature